Michael Ryskin
Stock Analyst at Bank of America Securities
(3.68)
# 2,080
Out of 4,517 analysts
680
Total ratings
53.2%
Success rate
3.2%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVO Evotec SE | Maintained: Sell | $2.4 | $1.97 | +21.95% | 10 | Jul 15, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $295 → $320 | $282.30 | +13.35% | 12 | Jul 13, 2026 | |
| MYGN Myriad Genetics | Maintained: Sell | $4 | $6.21 | -35.59% | 10 | Jul 13, 2026 | |
| DGX Quest Diagnostics | Maintained: Buy | $225 → $245 | $210.04 | +16.64% | 16 | Jul 13, 2026 | |
| NEO NeoGenomics | Maintained: Hold | $11 → $16 | $14.62 | +9.44% | 14 | Jul 13, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 | $156.71 | +21.24% | 18 | Jul 13, 2026 | |
| TEM Tempus AI | Maintained: Hold | $64 | $53.20 | +20.30% | 16 | Jul 13, 2026 | |
| CAI Caris Life Sciences | Reiterated: Buy | $28 → $23 | $16.61 | +38.47% | 8 | Jul 13, 2026 | |
| IDXX IDEXX Laboratories | Maintained: Hold | $660 | $561.92 | +17.45% | 32 | Jul 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Sell | $125 → $150 | $171.02 | -12.29% | 21 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $108 | $76.29 | +41.57% | 43 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $270 | $202.81 | +33.13% | 39 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $225.62 | - | 19 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $38 | $33.92 | +12.03% | 14 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $32 | $25.76 | +24.22% | 35 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 → $155 | $132.26 | +17.19% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $58.54 | +11.04% | 25 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $630 | $532.97 | +18.21% | 29 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $370 → $400 | $370.35 | +8.01% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $360.09 | - | 16 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $175 | $176.26 | -0.71% | 24 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 | $185.70 | -46.15% | 46 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $109.91 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $43.60 | - | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $41.08 | +19.28% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 | $206.32 | +18.75% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $27 | $25.95 | +4.05% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,307.08 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.32 | - | 22 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $9.5 | $17.90 | -46.93% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $28 | $19.33 | +44.87% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $11.07 | -0.63% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $7.16 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $6.94 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $8.03 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $8.47 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $2.98 | n/a | 2 | Apr 18, 2022 |
Evotec SE
Jul 15, 2026
Maintained: Sell
Price Target: $2.4
Current: $1.97
Upside: +21.95%
Labcorp Holdings
Jul 13, 2026
Maintained: Buy
Price Target: $295 → $320
Current: $282.30
Upside: +13.35%
Myriad Genetics
Jul 13, 2026
Maintained: Sell
Price Target: $4
Current: $6.21
Upside: -35.59%
Quest Diagnostics
Jul 13, 2026
Maintained: Buy
Price Target: $225 → $245
Current: $210.04
Upside: +16.64%
NeoGenomics
Jul 13, 2026
Maintained: Hold
Price Target: $11 → $16
Current: $14.62
Upside: +9.44%
Guardant Health
Jul 13, 2026
Reiterated: Buy
Price Target: $190
Current: $156.71
Upside: +21.24%
Tempus AI
Jul 13, 2026
Maintained: Hold
Price Target: $64
Current: $53.20
Upside: +20.30%
Caris Life Sciences
Jul 13, 2026
Reiterated: Buy
Price Target: $28 → $23
Current: $16.61
Upside: +38.47%
IDEXX Laboratories
Jul 7, 2026
Maintained: Hold
Price Target: $660
Current: $561.92
Upside: +17.45%
ICON Public Limited Company
Jun 24, 2026
Reiterated: Sell
Price Target: $125 → $150
Current: $171.02
Upside: -12.29%
Jun 16, 2026
Maintained: Hold
Price Target: $108
Current: $76.29
Upside: +41.57%
Jun 11, 2026
Reiterated: Buy
Price Target: $270
Current: $202.81
Upside: +33.13%
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $225.62
Upside: -
Jun 5, 2026
Maintained: Sell
Price Target: $38
Current: $33.92
Upside: +12.03%
Jun 5, 2026
Maintained: Buy
Price Target: $30 → $32
Current: $25.76
Upside: +24.22%
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $132.26
Upside: +17.19%
Jun 2, 2026
Reiterated: Buy
Price Target: $65
Current: $58.54
Upside: +11.04%
Jun 2, 2026
Maintained: Buy
Price Target: $630
Current: $532.97
Upside: +18.21%
Jun 2, 2026
Reiterated: Hold
Price Target: $370 → $400
Current: $370.35
Upside: +8.01%
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $360.09
Upside: -
May 27, 2026
Maintained: Sell
Price Target: $175
Current: $176.26
Upside: -0.71%
May 14, 2026
Maintained: Sell
Price Target: $100
Current: $185.70
Upside: -46.15%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $109.91
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $43.60
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $41.08
Upside: +19.28%
May 13, 2026
Maintained: Buy
Price Target: $245
Current: $206.32
Upside: +18.75%
May 12, 2026
Initiated Coverage: Hold
Price Target: $27
Current: $25.95
Upside: +4.05%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1,307.08
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $15.32
Upside: -
May 6, 2026
Reiterated: Sell
Price Target: $8 → $9.5
Current: $17.90
Upside: -46.93%
Mar 4, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $19.33
Upside: +44.87%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $11.07
Upside: -0.63%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $7.16
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $6.94
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $8.03
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $8.47
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $2.98
Upside: n/a